Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Syntimmune deal helps Alexion diversify beyond Soliris

Jennie Walters
September 28, 2018 5:35 PM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) took another step towards breaking its dependence on Soliris eculizumab on Sept. 26, when it announced it will acquire rare autoimmune disease company Syntimmune Inc. (Boston, Mass.).

Alexion will pay $400 million up front for Syntimmune, and the company’s shareholders, which include Apple Tree Partners, will be eligible for $800 million in milestones...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Alexion Pharmaceuticals Inc.

Apple Tree Partners

Syntimmune Inc.